KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Margin (2016 - 2025)

Gilead Sciences' FCF Margin history spans 17 years, with the latest figure at 39.39% for Q4 2025.

  • For Q4 2025, FCF Margin rose 203.0% year-over-year to 39.39%; the TTM value through Dec 2025 reached 32.12%, down 372.0%, while the annual FY2025 figure was 32.12%, 372.0% down from the prior year.
  • FCF Margin reached 39.39% in Q4 2025 per GILD's latest filing, down from 50.98% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 55.24% in Q3 2024 to a low of 10.17% in Q2 2025.
  • Average FCF Margin over 5 years is 32.76%, with a median of 32.81% recorded in 2023.
  • The largest YoY upside for FCF Margin was 3208bps in 2024 against a maximum downside of -1614bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 42.09% in 2021, then decreased by -23bps to 32.29% in 2022, then fell by -15bps to 27.47% in 2023, then skyrocketed by 36bps to 37.36% in 2024, then grew by 5bps to 39.39% in 2025.
  • Per Business Quant, the three most recent readings for GILD's FCF Margin are 39.39% (Q4 2025), 50.98% (Q3 2025), and 10.17% (Q2 2025).